Common Shares Outstanding: The number of class A shares currently held by investors.
Dermata Therapeutics, Inc. (DRMA) had Common Shares Outstanding of 0.64M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.70M |
|
-- |
|
-- |
|
$1.77M |
|
$-1.77M |
|
$0.07M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.70M |
|
$-1.77M |
|
$-1.77M |
|
1.03M |
|
1.03M |
|
$-1.66 |
|
$-1.66 |
|
| Balance Sheet Financials | |
$6.64M |
|
-- |
|
-- |
|
$6.64M |
|
$1.03M |
|
-- |
|
-- |
|
$1.03M |
|
$5.61M |
|
$5.61M |
|
$5.61M |
|
|
Common Shares Outstanding |
0.64M |
| Cash Flow Statement Financials | |
$-4.62M |
|
-- |
|
$7.94M |
|
$3.16M |
|
$6.48M |
|
$3.32M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.30% |
|
-30.30% |
|
-25.62% |
|
-30.30% |
|
$8.80 |
|
$-4.51 |
|
$-4.51 |
|